Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
54.11
-0.30 (-0.55%)
Sep 8, 2025, 4:00 PM - Market closed
Bio-Techne Revenue
In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth. Bio-Techne had revenue of $316.96M in the quarter ending June 30, 2025, with 3.55% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+5.23%
P/S Ratio
6.99
Revenue / Employee
$399,880
Employees
3,050
Market Cap
8.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TECH News
- 5 days ago - Bio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 12 days ago - Bio-Techne to Present at Upcoming Investor Conferences - PRNewsWire
- 25 days ago - ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory - PRNewsWire
- 4 weeks ago - Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Bio-Techne beats quarterly estimates on strength in protein sciences unit - Reuters
- 4 weeks ago - BIO-TECHNE DECLARES DIVIDEND - PRNewsWire
- 4 weeks ago - Bio-Techne Releases Fourth Quarter Fiscal 2025 Results - PRNewsWire
- 4 weeks ago - Bio-Techne Announces Exosome Diagnostics Divestiture - PRNewsWire